Oct 2026· Frontiers in Oncology· Vol 16· 0 citations· 104 references
TL;DR
Non-coding RNAs are underscores non-coding RNAs as a promising therapeutic target, offering a potential avenue for overcoming chemoresistance in cervical cancer.
Abstract
Drug resistance continues to pose a significant challenge, accounting for a large proportion of relapses and playing a major role in cervical cancer-related mortality worldwide. Emerging evidence has indicated that the aberrant expression of non-coding RNAs, especially circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), and microRNAs (miRNAs) is responsible for drug resistance, which poses a significant challenge to the success of chemotherapy. Addressing drug resistance is crucial for improving patient outcomes and reducing the burden of cervical cancer on healthcare systems. In this review, we summarize the molecular and cellular mechanisms through which circRNAs, miRNAs and lncRNAs mediate drug resistance to common drugs used in the treatment of cervical cancer. This work underscores non-coding RNAs as a promising therapeutic target, offering a potential avenue for overcoming chemoresistance in cervical cancer.
Chemoresistance remains one of the greatest challenges in modern oncology and is responsible for most cancer-related deaths. Growing evidence has identified non-coding RNAs (ncRNAs) as key regulators of resistance to anticancer therapy. These molecules influence a wide range of classical resistance mechanisms, includin...
I. Al-Janabi· Al-Rafidain Journal of Medic...· 0 citations
Malignant tumors remain a leading cause of global mortality, and the development of chemoresistance represents a major obstacle to effective cancer treatment. Long non-coding RNAs (lncRNAs) are important regulators of tumor progression and therapeutic response. Cancer susceptibility candidate 2 (CASC2) is an lncRNA tha...
Ling-Yun Zhou, Jin-Tao He, Wen-Bing Huang et al.· Journal of chemotherapy· 0 citations
The interplay between cell death pathways and the ncRNA regulatory networks profoundly influences chemoresistance in GC, andiphering these mechanisms offers a theoretical basis for developing biomarkers and combination strategies that overcome resistance, ultimately improving patient outcomes.
Ben-Shuai You, Yun Xu, Yang Yang· Current Oncology Reports· 0 citations
Head and neck squamous cell carcinomas (HNSCC) are the sixth most commonly diagnosed cancer globally, with a stagnant five-year survival rate of approximately 50%. Risk factors include human papillomavirus (HPV) infection, smoking, alcohol consumption, and betel nut chewing, contributing to its genetic and molecular he...
Feng-Xin Ge, Hui Yang, Xiang-Ze Wang et al.· Frontiers in Oncology· 0 citations
Prostate cancer (PCa) is the second most prevalent malignancy and a leading cause of can- cer-related mortality in males worldwide. Despite advancements in therapeutic strategies, such as radical prostatectomy, radiotherapy, androgen deprivation therapy (ADT), and chemotherapy, treatment outcomes for metastatic castrat...
Dharanidharan Dhanabalan, N. Shanmugam· Basic & Clinical Cancer...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
